Log In
BCIQ
Print this Print this
 

HORA-RLBP1

  Manage Alerts
Collapse Summary General Information
Company Horama S.A.S.
DescriptionSerotype 5 rAAV delivering the retinaldehyde binding protein 1 (RLBP1) gene
Molecular Target Retinaldehyde binding protein 1 (RLBP1)
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy: Viral vector: Adeno-associated virus (AAV)
Latest Stage of DevelopmentPreclinical
Standard IndicationRetinitis
Indication DetailsTreat retinitis punctata albescens
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today